CSF2 and cancer: However, although injection of antigenic peptides together with adjuvants like GM-CSF, or application of peptide-pulsed dendritic cells in some cases, resulted in antigen-specific T-cell responses in cancer patients, so far clinical responses have only rarely been observed (Jäger et al, 2002; Finn, 2003).